The World Health Organization has temporarily paused the use of anti-malaria drug hydroxychloroquine as part of a global effort to find a cure for Covid-19.
The organisation’s executive board made the decision following a study published in the medical journal The Lancet on 20 May that showed that the drug increased mortality rates among Covid-19 patients.
“The executive group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” the head of the WHO Dr Tedros Ghebreyesus told journalists in a virtual press briefing.
He said the other arms of the trial were continuing.
Hydroxycholoroquine has been touted by US President Donald Trump and other leaders as a possible treatment for Covid-19.
more recommended stories
Zimbabwe’s imposing new Chinese-funded parliament opens
HARARE, Zimbabwe — Zimbabwean President Emmerson.
Zimbabwe opposition leader Godfrey Sithole released on bail after 150 days in prison
Godfrey Sithole, an opposition lawmaker in.
‘South Africa’s Home Affairs lacks capacity to deal with Zimbabwean permit holder’
Immigration stakeholders such as the Helen.
Zimbabwe launches first ever nano satellite into space
Zimbabwe on Monday announced the launch.
19 reported dead in Tanzania plane crash
A Tanzanian passenger plane has crashed.
Four Zimbabweans part of 21 illegal miners found dead in South Africa mine
The African Diaspora Forum (ADF), an.
Zimbabwe’s ruling party backs leader Emmerson Mnangagwa despite huge inflation
HARARE, Zimbabwe (AP) — Zimbabwe’s president.
Museveni’s son General Muhoozi vows he will become president
The son of Uganda’s long-serving President.